ChiCTR1800016591
正在进行
/
/
/
2018-06-11
/
/
注意力缺陷多動障礙
A randomised controlled trial comparing MYmind with waitlist control among Chinese children with ADHD and their parents
A randomised controlled trial comparing MYmind with waitlist control among Chinese children with ADHD and their parents
1) To evaluate the effectiveness of a mindfulness-based intervention - MYmind - in improving children's attention, well-being, behaviour, resilience, family relationship and mindfulness level as well as reducing impulsivity associated with ADHD and health service use in children diagnosed with ADHD aged 8 to 18 years in Hong Kong. 2) To evaluate the effectiveness of MYmind in reducing parental stress and ADHD symptoms and improving well-being and rumination and reducing health service use among parents of children diagnosed with ADHD.
随机平行对照
治疗新技术
The randomisation will be conducted by an experienced independent statistician using computer-generated random results.
Participants will be informed of their group assignments. The research staff member who conducts the assessments or the statistical analysis will be kept blinded of the group assignment.
The D. H. Chen Foundation, Hong Kong SAR
/
140
/
2018-06-28
2021-06-27
/
Participants will include children and one parent of each child. However, the other parent of the same child is also welcome to participate in the mindfulness course but only their course attendance will be recorded to reduce the burden of the participating families. The inclusion criteria will be: 1) children aged 8 to 18 years with psychiatrist or psychologist diagnosed ADHD according to the Diagnostic and Statistical Manual of Mental Disorders - 5 (DSM-5) diagnostic criteria; and 2) with normal intellectual ability such that they can understand the materials delivered in MYmind and that they can complete home practice each week; and 3) children either not taking any medication or taking a stable dosage of the same medication for ADHD for at least 3 months prior to study enrolment and having no plan for changing medication during the study period.；
请登录查看The exclusion criteria of children and parents will be: 1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; 2) the child having comorbid conduct/behavior problems which are so severe that, during intake, the interaction between parent and assessor is interrupted by the child within 2 minutes, which makes it impossible for the child to participate in a group training. Instructions of this criterion are adapted from the Autism Diagnostic Observation Schedule (ADOS) and will be provided to the assessor to facilitate to examine whether the child may be or may not be able to participate in a group training in addition to the clinicians expertise; 3) having a medical or mental health condition rendering him/her to be incapable of participating in the study; and 4) previous participation in mindfulness-based training.；
请登录查看The D. H. Chen Foundation, Hong Kong SAR
/
皮肤好医荟2025-12-04
体外诊断原料网2025-12-04
优赛生命2025-12-04
医药时间2025-12-04
佰傲谷BioValley2025-12-04
求实药社2025-12-04
启迪之星2025-12-04
亚虹医药2025-12-04
幂方健康基金2025-12-04
汉氏联合2025-12-04
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
